COVID-19(8) Cancer(3) collected(2) hepatitis B(2) Patient(2) SARS-CoV-2(2) men(2) oncology(2) Future(2) restricted mean survival time.(1) Tyrosine kinase inhibitors.(1) less(1) TNF-α(1) SARS-CoV-2 pandemic(1) antibodies(1) Chemotherapy(1) men and women(1) Quality of life.(1) Gender(1) dataset(1) antibody(1) HBV(1) Necrosis(1) endothelial(1) VEGF(1) demographic characteristics(1) anti-Spike IgG(1) sorafenib(1) IL-6(1) comprehensive cancer center(1)